Keyphrases
Alpha-1 Antitrypsin Deficiency
100%
Lung Disease
26%
Early Treatment
24%
Lung Function
23%
Liver Disease
22%
Early Diagnosis
22%
Bronchiectasis
18%
Primary Care
16%
Chronic Obstructive Pulmonary Disease
13%
Sputum Samples
13%
PiZZ
13%
Computed Tomography
12%
COVID-19
11%
Respiratory Specialists
11%
Systematic Meta-analysis
11%
Tukey
11%
Liver Targeting
11%
Random Effects Model
11%
Freeman
11%
Health Status
11%
Transplantation
11%
Pulmonary Function Test
11%
Status Functions
11%
Severe Acute Respiratory Syndrome
11%
Cluster Randomized Trial
11%
Meta-analysis
11%
Mixed-methods Study
11%
Middle East Respiratory Syndrome
11%
Experimental Drugs
11%
Targeted Treatment
11%
Investigational Drugs
11%
Acute Exacerbation of COPD (AECOPD)
11%
Daily Symptoms
11%
Symptom Diary
11%
Urinary Biomarkers
11%
Disease Exacerbation
11%
Bacterial Colonization
11%
Emphysema
9%
Disease Progression
9%
GP Practice
8%
Guideline Adherence
8%
Alpha-1 Antitrypsin
8%
COVID-19 Infection
7%
Liver Transplantation
7%
Liver
7%
PiSZ
6%
Genotype
6%
Clinical Trials
5%
Aliquot
5%
Quantitative Bacterial Culture
5%
Medicine and Dentistry
Alpha 1-Antitrypsin Deficiency
66%
Chronic Obstructive Pulmonary Disease
31%
Early Diagnosis
22%
Silo-Filler's Disease
17%
Primary Health Care
17%
Lung
15%
Liver Disease
14%
Systematic Review
13%
Biological Marker
13%
Targeted Therapy
12%
Severe Acute Respiratory Syndrome
11%
COVID-19
11%
Meta-Analysis
11%
Random Effects Model
11%
Computer Assisted Tomography
11%
Randomized Controlled Trial
11%
Health Status
11%
Diagnostic Error
11%
Lung Function Test
11%
Middle East Respiratory Syndrome
11%
Urinary System
11%
Bacterial Colonization
11%
Diseases
9%
Infection
8%
Liver Transplantation
7%
Prevalence
6%
Alpha 1 Antitrypsin
5%
Disease Exacerbation
5%
